Breakout Ventures Launches a $114 Million Fund for AI Science Startups

Breakout Ventures has closed a $114 million fund to invest in AI-focused science startups.

Breakout Ventures Launches a $114 Million Fund for AI Science Startups
Breakout Ventures announces $114 million fund for AI science startups

Breakout Ventures, a San Francisco-based venture capital firm, has recently closed its third fund, called Fund III, with a commitment of $114 million. The fund is intended to support early-stage startups that use artificial intelligence to tackle scientific challenges in fields such as biology and chemistry.

Investment Strategy and Fund Goals

The fund aims to invest in at least 20 companies, with investment sizes ranging from $500,000 to $5 million. Lindy Fishburne, managing director of Breakout Ventures, stressed the importance of "unlocking the complexity of science with AI". The firm has already invested in three companies and plans to further expand its portfolio in the coming years.

Breakout Ventures' Origins and Growth

Founded in 2016 as a spin-off of the Breakout Labs grant program of the Thiel Foundation, Breakout Ventures previously raised two funds: a $60 million fund in 2017 and another of $112.5 million in 2021, both focused on science startups. With the current raise, the firm has surpassed $230 million in assets under management.

Partnerships and Investor Support

Fund III received backing from existing investors such as The Kraft Group, Pinegrove Venture Partners and S-Cubed Capital. In addition, new partners joined, including JIMCO, the global investment arm of the Jameel family, and Korea Omega Investment Corporation. These investors share Breakout Ventures' vision of promoting scientific innovation through AI.

Implications for the Science Startup Sector

The growth of investment in startups combining AI and science points to growing confidence in the potential of these technologies to tackle complex scientific challenges. Companies focused on biology, chemistry and other fundamental sciences can significantly benefit from AI-based solutions, accelerating research and development of new products and therapies.

Conclusion

  • Focus on AI and Science: Breakout Ventures concentrates its investments on startups using AI to solve complex scientific problems.
  • Portfolio Expansion: With Fund III, the firm plans to invest in at least 20 new companies in the coming years.
  • Investor Support: The fund has attracted both existing and new investors, highlighting growing interest in scientific innovation.
  • Opportunities in the Scientific Sector: Integrating AI into science offers opportunities to accelerate research and development of new products and therapies.
  • Market Impact: Breakout Ventures' initiative could spur further investment in startups combining technology and science, promoting innovation in the sector.